Unlike other Canadian provinces and jurisdictions, the Quebec government imposes rules and constraints on private drug plans that affects pharmacy costs. For example, in all provinces except Quebec, the amounts billed by pharmacies to private drug claims are controlled through the following measures: fees are displayed in pharmacies so patients can compare — however, the […]
Changes to Quebec’s policy on the use of biosimilars in its public drug plan could result in savings for private benefits plans, says one expert. On April 13, 2022, the Régie de l’assurance maladie du Québec will delist certain biologic drugs from its formulary, requiring patients covered by the plan to switch to a biosimilar […]